ArticlePloS one2022

Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients.

Celine Johanna van de Laar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.